14-94304471-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_001756.4(SERPINA6):c.1165G>A(p.Asp389Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000358 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00051 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 0 hom. )
Consequence
SERPINA6
NM_001756.4 missense
NM_001756.4 missense
Scores
1
8
9
Clinical Significance
Conservation
PhyloP100: 3.96
Genes affected
SERPINA6 (HGNC:1540): (serpin family A member 6) This gene encodes an alpha-globulin protein with corticosteroid-binding properties. This is the major transport protein for glucorticoids and progestins in the blood of most vertebrates. The gene localizes to a chromosomal region containing several closely related serine protease inhibitors which may have evolved by duplication events. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 14-94304471-C-T is Pathogenic according to our data. Variant chr14-94304471-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 16975.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Likely_pathogenic=1}. Variant chr14-94304471-C-T is described in UniProt as null. Variant chr14-94304471-C-T is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.013436496). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINA6 | NM_001756.4 | c.1165G>A | p.Asp389Asn | missense_variant | 5/5 | ENST00000341584.4 | NP_001747.3 | |
SERPINA6 | XM_047431827.1 | c.1336G>A | p.Asp446Asn | missense_variant | 5/5 | XP_047287783.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPINA6 | ENST00000341584.4 | c.1165G>A | p.Asp389Asn | missense_variant | 5/5 | 1 | NM_001756.4 | ENSP00000342850.3 | ||
SERPINA6 | ENST00000555056.1 | n.*477G>A | non_coding_transcript_exon_variant | 5/5 | 2 | ENSP00000451045.1 | ||||
SERPINA6 | ENST00000555056.1 | n.*477G>A | 3_prime_UTR_variant | 5/5 | 2 | ENSP00000451045.1 |
Frequencies
GnomAD3 genomes AF: 0.000507 AC: 77AN: 152000Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
77
AN:
152000
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000617 AC: 155AN: 251322Hom.: 0 AF XY: 0.000567 AC XY: 77AN XY: 135852
GnomAD3 exomes
AF:
AC:
155
AN:
251322
Hom.:
AF XY:
AC XY:
77
AN XY:
135852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000343 AC: 501AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.000355 AC XY: 258AN XY: 727248
GnomAD4 exome
AF:
AC:
501
AN:
1461892
Hom.:
Cov.:
31
AF XY:
AC XY:
258
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000506 AC: 77AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.000471 AC XY: 35AN XY: 74368
GnomAD4 genome
AF:
AC:
77
AN:
152118
Hom.:
Cov.:
32
AF XY:
AC XY:
35
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
62
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Corticosteroid-binding globulin deficiency Pathogenic:3Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 12, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2007 | - - |
Likely pathogenic, no assertion criteria provided | curation | Reproductive Health Research and Development, BGI Genomics | Jan 06, 2020 | NM_001756.3:c.1165G>A in the SERPINA6 gene has an allele frequency of 0.007 in Ashkenazi Jewish subpopulation in the gnomAD database. It was detected in individual with autosomal recessive Corticosteroid-binding globulin deficiency, two homozygous c.1165G>A(PMID: 12780753; 20610591). Co-segregation evidence in a pedigree, two patients were affected and one sibling unaffected (PMID: 20610591). Pathogenic computational verdict because 9 pathogenic predictions from DANN, DEOGEN2, EIGEN, FATHMM-MKL, M-CAP, MVP, MutationAssessor, MutationTaster and REVEL. Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP criteria applied: PP1_Moderate; PM3; PP4; PP3. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 26, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Jan 30, 2020 | - - |
SERPINA6-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 09, 2024 | The SERPINA6 c.1165G>A variant is predicted to result in the amino acid substitution p.Asp389Asn. This variant, also referred to as CBG Lyon or p.Asp367Asn, has been reported in the heterozygous and homozygous state in individuals with corticosteroid-binding globulin (CBG) deficiency (Emptoz-Bonneton et al. 2000. PubMed ID: 10634411; Brunner et al. 2003. PubMed ID: 12780753; Cizza et al. 2011. PubMed ID: 21795453). Functional studies found this variant resulted in reduced affinity for cortisol and results in low or low-normal serum cortisol levels in homozygous and heterozygous subjects (Emptoz-Bonneton et al. 2000. PubMed ID: 10634411; Brunner et al. 2003. PubMed ID: 12780753; Cizza et al. 2011. PubMed ID: 21795453). This variant is reported in 0.77% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. In ClinVar this variant has conflicting interpretations of pathogenicity of uncertain, likely pathogenic, and pathogenic (https://ncbi.nlm.nih.gov/clinvar/variation/16975/). This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at